All
FDA sends warning letters to dietary supplement companies claiming to treat cardiovascular disease
November 18th 2022On November 17, the agency sent warning letters to Essential Elements, Calroy Health Sciences, Iwi, BergaMet North America, Healthy Trends Worldwide, Chambers’ Apothecary, and Anabolic Laboratories.